Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Ther Apher Dial ; 26(4): 827-835, 2022 Aug.
Article in English | MEDLINE | ID: mdl-34812590

ABSTRACT

INTRODUCTION: Quantitative measurement of anti-A/-B antibody titers is important during ABO-incompatible living kidney transplantation (ABOi-LKT). METHODS: We conducted a multi-institutional study to measure the antibody titers using the automated column agglutination technique (auto-CAT) and tube test (TT) method in ABOi-LKT recipients. Statistical analysis was performed to evaluate the two methods. RESULTS: We examined 111 samples from 35 ABOi-LKT recipients at four institutions. The correlation coefficient of the two methods was >0.9; the concordance rate and clinically acceptable concordance rate for the IgG titers were 60.4% and 88.3%, respectively. Perioperative status did not influence the statistical significance. Parallel changes were observed in the IgG antibody titers measured using the auto-CAT or TT technique by desensitizing therapy in time-course monitoring. CONCLUSION: Auto-CAT is comparable with the TT technique and is feasible for IgG anti-A/B antibody titration in ABOi-LKT recipients.


Subject(s)
Kidney Transplantation , ABO Blood-Group System , Agglutination , Blood Group Incompatibility , Feasibility Studies , Graft Rejection , Immunoglobulin G , Kidney Transplantation/methods , Living Donors
2.
Front Immunol ; 12: 740517, 2021.
Article in English | MEDLINE | ID: mdl-34603326

ABSTRACT

Background: Although intravenous immunoglobulin (IVIG) therapy is generally safe and well tolerated, adverse reactions (ARs) do occur. The majority of these ARs are mild and transient. Risk factors for ARs associate with IVIG infusions are not well established. This study investigated possible risk factors influencing the occurrence of IVIG-associated ARs. Study Design and Methods: This was a retrospective observational analysis of data accumulated over 5 years, including patient demographics, clinical condition, IVIG dosing regimens, number of IVIG infusions, and any ARs. Results: ARs were associated with IVIG in 4.9% of patients and 2.5% of infusions. By univariate analyses, ARs correlated with female sex, adult age, high dose IVIG, and autoimmune disease. Multivariate logistic regression identified three statistically significant of risk factors: on a per-patient basis, being female (p=0.0018), having neuromuscular disease (p=0.0002), and receiving higher doses of IVIG per patient body weight (p<0.001), on a per-infusion basis, being female (p < 0.001), being adolescents to middle age (p < 0.001), and having neuromuscular disease (p < 0.001). Conclusion: Neuromuscular disease emerged as one of the significant factors for ARs to IVIG.


Subject(s)
Autoimmune Diseases/drug therapy , Drug-Related Side Effects and Adverse Reactions/epidemiology , Immunoglobulins, Intravenous/adverse effects , Immunologic Factors/adverse effects , Neuromuscular Diseases/drug therapy , Sex Factors , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Drug Dosage Calculations , Female , Humans , Immunoglobulins, Intravenous/therapeutic use , Immunologic Factors/therapeutic use , Infant , Infant, Newborn , Japan/epidemiology , Male , Middle Aged , Neuromuscular Diseases/epidemiology , Prevalence , Retrospective Studies , Risk , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...